GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (STU:08HH) » Definitions » Shiller PE Ratio

Shanghai Fosun Pharmaceutical (Group) Co (STU:08HH) Shiller PE Ratio : 17.12 (As of May. 04, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio?

As of today (2025-05-04), Shanghai Fosun Pharmaceutical (Group) Co's current share price is €1.541. Shanghai Fosun Pharmaceutical (Group) Co's E10 for the quarter that ended in Mar. 2025 was €0.09. Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio for today is 17.12.

The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio or its related term are showing as below:

STU:08HH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.3   Med: 28.15   Max: 68.81
Current: 17.67

During the past years, Shanghai Fosun Pharmaceutical (Group) Co's highest Shiller PE Ratio was 68.81. The lowest was 16.30. And the median was 28.15.

STU:08HH's Shiller PE Ratio is ranked better than
68.82% of 526 companies
in the Drug Manufacturers industry
Industry Median: 24.56 vs STU:08HH: 17.67

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Mar. 2025 was €0.037. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €0.09 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.03 38.38 26.21 18.94 18.83

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.38 16.84 20.84 18.83 18.74

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio falls into.


;
;

Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1.541/0.09
=17.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co's E10 for the quarter that ended in Mar. 2025 is calculated as:

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.037/115.1156*115.1156
=0.037

Current CPI (Mar. 2025) = 115.1156.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201506 0.047 99.500 0.054
201509 0.035 100.500 0.040
201512 0.034 100.600 0.039
201603 0.037 102.200 0.042
201606 0.051 101.400 0.058
201609 0.039 102.400 0.044
201612 0.036 102.600 0.040
201703 0.042 103.200 0.047
201706 0.050 103.100 0.056
201709 0.037 104.100 0.041
201712 0.036 104.500 0.040
201803 0.036 105.300 0.039
201806 0.046 104.900 0.050
201809 0.025 106.600 0.027
201812 0.031 106.500 0.034
201903 0.037 107.700 0.040
201906 0.040 107.700 0.043
201909 0.028 109.800 0.029
201912 0.063 111.200 0.065
202003 0.030 112.300 0.031
202006 0.055 110.400 0.057
202009 0.037 111.700 0.038
202012 0.058 111.500 0.060
202103 0.043 112.662 0.044
202106 0.083 111.769 0.085
202109 0.055 112.215 0.056
202112 0.064 113.108 0.065
202203 0.026 114.335 0.026
202206 0.059 114.558 0.059
202209 0.049 115.339 0.049
202212 0.066 115.116 0.066
202303 0.050 115.116 0.050
202306 0.039 114.558 0.039
202309 0.023 115.339 0.023
202312 0.004 114.781 0.004
202403 0.029 115.227 0.029
202406 0.029 114.781 0.029
202409 0.037 115.785 0.037
202412 0.038 114.893 0.038
202503 0.037 115.116 0.037

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Fosun Pharmaceutical (Group) Co  (STU:08HH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co Business Description

Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.

Shanghai Fosun Pharmaceutical (Group) Co Headlines

No Headlines